Expression of a constitutively active β‐catenin in mouse OBs resulted in overexpression of the Notch ligand Jagged1 (JAG1), and subsequent development of AML.(43) Furthermore, inhibition of the Notch pathway in an AML model lessened leukemic development. The gene discussed is JAG1; the disease is acute myeloid leukemia.